IDEX (NYSE:IEX) PT Lowered to $231.00

IDEX (NYSE:IEXGet Rating) had its target price decreased by Stifel Nicolaus from $244.00 to $231.00 in a research report issued on Monday, The Fly reports. Stifel Nicolaus’ price objective suggests a potential upside of 21.22% from the company’s previous close.

Other analysts have also issued research reports about the company. Zacks Investment Research upgraded IDEX from a “hold” rating to a “buy” rating and set a $213.00 price objective for the company in a report on Friday, February 4th. StockNews.com started coverage on IDEX in a research report on Thursday, March 31st. They issued a “buy” rating on the stock. Robert W. Baird cut their price target on IDEX from $251.00 to $233.00 in a research report on Thursday, February 3rd. Loop Capital cut their price target on IDEX from $225.00 to $210.00 in a research report on Monday, April 4th. Finally, Cowen raised IDEX from a “market perform” rating to an “outperform” rating and set a $220.00 price target on the stock in a research report on Wednesday, March 9th. Four investment analysts have rated the stock with a hold rating and nine have given a buy rating to the company’s stock. Based on data from MarketBeat.com, the stock has an average rating of “Buy” and a consensus target price of $235.15.

IDEX stock opened at $190.56 on Monday. The business has a fifty day moving average of $192.90 and a two-hundred day moving average of $213.53. The company has a quick ratio of 2.72, a current ratio of 3.50 and a debt-to-equity ratio of 0.42. The firm has a market cap of $14.50 billion, a P/E ratio of 32.41, a P/E/G ratio of 2.10 and a beta of 1.11. IDEX has a twelve month low of $181.66 and a twelve month high of $240.33.

IDEX (NYSE:IEXGet Rating) last issued its quarterly earnings data on Tuesday, February 1st. The industrial products company reported $1.55 EPS for the quarter, missing the consensus estimate of $1.59 by ($0.04). IDEX had a net margin of 16.26% and a return on equity of 17.82%. The business had revenue of $714.80 million for the quarter, compared to analysts’ expectations of $705.84 million. During the same quarter in the prior year, the company posted $1.37 EPS. The business’s revenue for the quarter was up 16.3% on a year-over-year basis. Equities analysts expect that IDEX will post 7.55 earnings per share for the current year.

Large investors have recently bought and sold shares of the company. Bell Investment Advisors Inc acquired a new stake in shares of IDEX during the 3rd quarter valued at about $25,000. CVA Family Office LLC purchased a new position in IDEX in the 4th quarter valued at about $27,000. EverSource Wealth Advisors LLC purchased a new position in IDEX in the 4th quarter valued at about $31,000. Dark Forest Capital Management LP purchased a new position in IDEX in the 3rd quarter valued at about $32,000. Finally, Consolidated Planning Corp purchased a new position in IDEX in the 3rd quarter valued at about $37,000. Hedge funds and other institutional investors own 97.35% of the company’s stock.

IDEX Company Profile (Get Rating)

IDEX Corporation, together with its subsidiaries, provides applied solutions worldwide. The company operates through three segments: Fluid & Metering Technologies (FMT), Health & Science Technologies (HST), and Fire & Safety/Diversified Products (FSDP). The FMT segment designs, produces, and distributes positive displacement pumps, small volume provers, flow meters, injectors, and other fluid-handling pump modules and systems, as well as offers flow monitoring and other services for the food, chemical, general industrial, water and wastewater, agricultural, and energy industries.

See Also

The Fly logo

Analyst Recommendations for IDEX (NYSE:IEX)

Receive News & Ratings for IDEX Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for IDEX and related companies with MarketBeat.com's FREE daily email newsletter.